Wynzora 64 mg/g
Calcipotriene and Betamethasone dipropionate · CREAM · MC2 Therapeutics Ltd
No Recall History
Plain English
Wynzora is a cream containing calcipotriene and betamethasone dipropionate at 64 mg/g, taken topical. Manufactured by MC2 Therapeutics Ltd.
Key Facts
- Brand Name
- Wynzora
- Generic Name
- Calcipotriene and Betamethasone dipropionate
- NDC Code (Product)
73499-001- Manufacturer
- MC2 Therapeutics Ltd
- Strength
- 64 mg/g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- NDA213422
- Drug Class
- Vitamin D Analog [EPC]
- Marketing Start
- 06/30/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Wynzora used for?
Wynzora contains Calcipotriene and Betamethasone dipropionate. It is a cream taken topical. Consult your doctor for specific uses.
Is Wynzora a controlled substance?
Wynzora is not classified as a controlled substance by the DEA.
What is the generic name for Wynzora?
The generic name for Wynzora is Calcipotriene and Betamethasone dipropionate. There are 5 other brand versions of Calcipotriene and Betamethasone dipropionate.
What is the NDC code for Wynzora 64 mg/g?
The NDC (National Drug Code) for Wynzora 64 mg/g is 73499-001, listed by MC2 Therapeutics Ltd.